Myriad Genetics | MYGN - Заемный капитал





Заемный капитал Изменить Дата
Agilent USD 3.05B 0 2025-12
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Danaher USD 17.56B 855M 2026-03
Illumina USD 1.49B 0 2026-03
J&J USD 37.53B 1.91B 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Quidel USD 0 2.47B 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
Standard Biotools USD 299K 0 2025-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Veracyte USD 0 0 2025-03
Waters USD 5.22B 3.81B 2026-03